Commercialism, choice and consumer protection: regulation of complementary medicines in Australia

Nigel A Pollard
Med J Aust 2008; 189 (1): . || doi: 10.5694/j.1326-5377.2008.tb01901.x
Published online: 7 July 2008

To the Editor: In the January issue of the Journal, Harvey et al raised some serious concerns about the listing system for complementary medicines.1 In particular, they suggest scrapping the listing system (AUST L) and requiring complementary medicine (CM) products to be evaluated by the Therapeutic Goods Administration (TGA) for efficacy.

  • Nigel A Pollard

  • Flordis Natural Medicines, Sydney, NSW.


Competing interests:

I am the Managing Director of an Australian complementary medicine company, and own shares in that company. No company product names have been mentioned, and the letter is an industry view on an article which examines issues in relation to complementary medicine products promoted in Australia.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.